Connect with us

MAM

How Covid spurred a turnaround for India’s e-pharma industry

Published

on

Mumbai: According to a 2019 EY report, the Indian e-pharma sector was poised to touch $2.7 billion by 2023 from $360 million. The report cited an increase in internet penetration and smartphone ownership, along with the ease of ordering medications through an e-commerce platform and an increase in chronic diseases as some of the key growth drivers for the online pharma industry.

And this was before the Covid-19 put a gigantic spoke in the wheel of our outdoor activities. And, before it became hara-kiri to step out of one’s house for as mundane a task as purchasing some prescription pills.

The Covid Tsunami Effect

One year plus of the tidal onslaught of the Covid tsunami has brought about irrevocable changes into the world. The exponential and fast-tracked tilt towards everything digital was one of them and it was obvious that online pharmacies and healthcare would not be far behind.

“With limited reach and usage till a year ago, the pandemic has changed the landscape drastically. Lockdowns, restricted movement, and policy initiatives have enabled higher adoption, penetration, and substantial growth,” says digital marketing agency Natter COO Avinash Joshi as he opines on the growth in India’s e-pharma space.

Advertisement

High caseloads, especially in urban areas coupled with regional lockdowns have compelled consumers to take the online route rather than visit the friendly neighbourhood pharmacies. It’s no longer simply a matter of convenience but about undertaking any added risk by venturing out unnecessarily.

Driven by the second wave of the Covid-19 pandemic, India’s e-pharmacy sector is once again witnessing a surge in orders. There has also been a spike in sales of Covid-related products – such as pulse oximeters, personal protective equipment (PPE) kits, oxygen cans, masks, sanitizers, health supplements across major online pharma players, in addition to regular drugs. 

Overall Growth in the e-Sector

According to dentsu Impact president Amit Wadhwa, the e-pharma sector in India is still in its nascent stage and while it has been growing rapidly in the last 4-5 years in India, a big surge in that growth happened only over the last one year. “This is not just visible in the industry growth numbers and how we are seeing consumers using/ talking about the platform, but also with the number of new players that we are constantly seeing entering this segment, with even traditional chemists such as Apollo Pharmacy along with big names such as Amazon diving right in,” says Wadhwa.

As per estimates, 35 per cent of the domestic pharmaceutical market relates to chronic medications and the remainder to acute medicines. E-pharmacies have been targeting the chronic market majorly so far and are expected to scale up the acute medicine market through an improvement in last-mile logistics and collaboration with local pharmacies.

Advertisement

“In the years to come, people will look at 2020 as ‘the year that changed everything- especially the way we reach out to our end consumers’,” says Hybrid healthcare start up Healthnovo co-founder Rima Sunit. “We see an increasing trend of teleconsultation, online ordering of medicines, etc. Even doctors are now adapting to new methods of providing prescriptions by using digital tools and consulting their patients over a video call. Currently, the Indian market is flooded by online players offering the best services at discounted prices.”

According to industry trackers, the sector’s growth is on top of an already robust revenue increase of around 35 per cent last year. The second wave and the consequent uptick in orders are setting the industry up for yet another year of strong growth in the range of 30-50 per cent. An almost 3X expansion in the number of users ordering medicines online means the sector is bound to see strong revenue growth this year as well.

Major players & their marketing game

Some of the leading players in this race to tap into the burgeoning e-pharma sector are 1mg, Netmeds, Pharmeasy, and Medlife with many new entrants emerging on the scene. In the last few months, brands like PharmEasy have been wooing the customer with a deluge of commercials, amplifying their message of ‘Aapki Health Aapke Haath Mein hai’ (your health is in your hands), with a dash of humour and relatability to the common man.

Netmeds roped in celebrity brand ambassador, Kareena Kapoor to convey the reliability and safety of their service, coupled with the ease and convenience of access for the customer.

Advertisement

According to Wadhwa, the brands are focusing their messaging on discounts and ease of delivery as ‘this is a phase where the category is creating awareness and the intent is to gain from the physical chemists’. He adds, “As the category gains more acceptance, we will see a more defined and differentiated messaging/ tonality across at least the key brands where possibly more planks such as trust, presence, etc. might be explored.”

Reaping the benefits of increased demand, online pharmacies and digital health companies have been passing on some of the paybacks to consumers by offering generous discounts on online purchases. This helped drive up the sales initially, while brands were trying to make a dent in the hitherto traditional Indian pharma market. In the long run, however, discounts may have to come down to reasonable levels to achieve breakeven and any meaningful profitability.

“With several local & global players in the fray, a lot of money is being spent to own and retain that exclusive audience. These brands are spending big on ATL and driving performance on digital with retargeting, scaling up downloads, offering discounts & referrals. These digital-first brands make use of chat-bots for queries & resolutions, AI & ML for recommendations, and tracking tools & digital payments for fulfilment. They are also spending big on content creation to engage with the user on the right platform,” says Natter COO Avinash Joshi.

Despite challenges like trust deficit, customer support issues, and remote area access, if the spurt in the e- pharma industry continues, it can aid in the regulation of the Indian pharma space. As e-pharma companies insist on verifying the prescription online before dispensing medicine they are likely to be more structured than their traditional counterparts.

Advertisement

Brands

Netflix India names Rekha Rane director of films and series marketing

Streaming giant bets on a seasoned marketer who helped build Amazon and Netflix into household names

Published

on

MUMBAI: Netflix has put a proven brand builder at the helm of its films and series marketing in India, naming Rekha Rane as director in a move that signals sharper focus on audience growth and cultural cut-through in one of its most hotly contested markets.

Rane steps into the role after seven years at Netflix, where she has quietly shaped how the platform sells stories to India. Her latest promotion, effective February 2026, crowns a run that spans brand, slate and product marketing across originals, licensed content and new verticals such as games.

A strategic marketing and communications professional with roughly 15 years’ experience, Rane has spent much of her career building technology-led consumer businesses and new categories, notably e-commerce and subscription video on demand. She was part of the early push that introduced Amazon.in, Prime Video and Netflix to Indian homes, then helped turn them into everyday brands.

At Netflix, she most recently served as head of brand and slate marketing for India from March 2024 to February 2026, leading teams across media and marketing for global and local content portfolios. Before that, as manager for original films and series marketing, she led IP creation and go-to-market strategy for titles including Guns and Gulaabs, Kaala Paani, The Railway Men* and The Great Indian Kapil Show, spanning both binge and weekly-release formats.

Her earlier Netflix roles covered product discovery and promotion in India and integrated campaign strategy to drive conversations around the content slate, product awareness and brand-equity metrics.

Advertisement

Before Netflix, Rane logged more than three years at Amazon in brand marketing roles in Bengaluru. There she handled national and regional campaigns for Amazon.in, worked on customer assistance programmes in growth geographies and contributed to the go-to-market strategy for the launch of Prime Video India.

Her career began well away from streaming. At Reliance Brands in Mumbai, she worked on retail marketing for Diesel and Superdry. A stint at Leo Burnett saw her work on primary research for P&G Tide, mapping Indian shoppers’ paths to purchase. Earlier still, at Orange in the United Kingdom, she rose from sales assistant to store manager, running a team and owning monthly P&L for a retail outlet.

The arc is telling. As global streamers fight for attention in a crowded Indian market, executives who understand both mass retail behaviour and digital habit-building are prized. Rane’s career sits at that intersection.

For Netflix, the bet is simple: in a market spoilt for choice, sharp marketing can still tilt the screen. And with Rane now leading the charge, the streamer is signalling it wants not just viewers, but fandom.

Advertisement
Continue Reading

Brands

Orient Beverages pops the fizz with steady Q3 gains and rising profits

Kolkata-based beverage maker reports stronger revenues and profits for December quarter.

Published

on

MUMBAI: A fizzy quarter with a steady aftertaste that’s how Orient Beverages Limited, the company that manufactures and distributes packaged drinking water under the brand name Bisleri closed the December 2025 period, as the Kolkata-based drinks maker reported improved revenues and a healthy rise in profits, signalling operational stability in a competitive beverage market.

For the quarter ended December 31, 2025, Orient Beverages posted standalone revenue from operations of Rs 39.98 crore, up from Rs 36.42 crore in the previous quarter and Rs 33.53 crore in the same quarter last year. Total income for the quarter stood at Rs 42.24 crore, reflecting consistent demand and stable pricing across its beverage portfolio.

Profit before tax for the quarter came in at Rs 3.47 crore, a sharp improvement from Rs 1.31 crore in the September quarter and Rs 0.39 crore a year ago. After accounting for tax expenses of Rs 0.79 crore, the company reported a net profit of Rs 2.68 crore, nearly three times the Rs 0.99 crore recorded in the preceding quarter.

On a nine-month basis, the momentum remained intact. Revenue from operations for the period ended December 31, 2025 rose to Rs 117.66 crore, compared with Rs 106.95 crore in the corresponding period last year. Net profit for the nine months climbed to Rs 5.51 crore, more than double the Rs 2.18 crore reported in the same period of the previous financial year.

The consolidated numbers told a similar story. For the December quarter, consolidated revenue from operations stood at Rs 45.06 crore, while profit after tax came in at Rs 2.06 crore. For the nine-month period, consolidated revenue touched Rs 133.57 crore, with net profit of Rs 4.49 crore, underscoring the group’s improving profitability trajectory.

Advertisement

Operating expenses remained largely controlled, with cost of materials, employee benefits and other expenses broadly aligned with revenue growth. The company continued to operate within a single reportable segment beverages simplifying its cost structure and reporting framework.

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 7 February 2026. Statutory auditors carried out a limited review and reported no material misstatements in the results.

In a market where margins are often squeezed by input costs and competition, Orient Beverages’ latest numbers suggest the company has found a reliable rhythm not explosive, but steady enough to keep the fizz alive.

Continue Reading

MAM

Washington Post CEO exits abruptly after newsroom cuts spark backlash

Leadership change follows layoffs, protests and a bruising battle over trust.

Published

on

MUMBAI: When the presses are rolling but patience runs out, even the editor’s chair isn’t safe. The Washington Post announced on Saturday that its chief executive and publisher Will Lewis is stepping down with immediate effect, bringing a sudden end to a turbulent two-year tenure marked by financial strain, newsroom unrest and public backlash.

Lewis’s exit comes just days after the Bezos-owned newspaper announced sweeping job cuts that triggered protests outside its Washington headquarters and a wave of anger from readers and staff. While newspapers across the US are grappling with shrinking revenues and digital disruption, Lewis’s leadership had increasingly come under fire for how those pressures were handled.

The Post confirmed that Jeff D’Onofrio, a former Tumblr CEO who joined the organisation last year as chief financial officer, has taken over as CEO and publisher, effective immediately. In an email to staff, later shared by reporters on social media, Lewis said it was “the right time for me to step aside.”

The leadership change follows the announcement of large-scale redundancies earlier this week. While the Post did not officially confirm numbers, The New York Times reported that around 300 of the paper’s roughly 800 journalists were laid off. Entire teams were dismantled, including the Post’s Middle East bureau and its Kyiv-based correspondent covering the war in Ukraine.

Sports, graphics and local reporting were sharply reduced, and the paper’s daily podcast, Post Reports, was suspended. On Thursday, hundreds of journalists and supporters gathered outside the Post’s downtown office in protest, calling the cuts a blow to public-interest journalism.

Advertisement

Former executive editor Marty Baron described the moment as “among the darkest days in the history of one of the world’s greatest news organisations.”

Lewis defended his record in his farewell note, saying “difficult decisions” were taken to secure the paper’s long-term future and protect its ability to publish “high-quality nonpartisan news”. But his tenure coincided with growing scrutiny of editorial independence at the Post.

Owner Jeff Bezos faced criticism for reining in the paper’s traditionally liberal editorial page and blocking an endorsement of Democratic presidential candidate Kamala Harris ahead of the 2024 US election. The move was widely seen as breaking the long-standing firewall between ownership and editorial decision-making.

According to a Wall Street Journal report, around 250,000 digital subscribers cancelled their subscriptions after the paper declined to endorse Harris. The Post reportedly lost about $100 million in 2024 as advertising and subscription revenues slid.

While the wider newspaper industry continues to battle declining print advertising and the pull of social media, some national titles have stabilised. Rivals such as The Wall Street Journal and The New York Times have managed to build sustainable digital businesses, a turnaround that has so far eluded the Post despite its billionaire backing.

Advertisement

As Jeff D’Onofrio steps into the role, the challenge is stark, restore confidence inside the newsroom, win back readers who walked away, and prove that one of America’s most storied newspapers can still find its footing in a brutally competitive media landscape.

Continue Reading
Advertisement CNN News18
Advertisement whatsapp
Advertisement ALL 3 Media
Advertisement Year Enders

Trending

Copyright © 2026 Indian Television Dot Com PVT LTD